✦ LIBER ✦

104 Phase II study of emitefur (BOF-A2) in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Niitani, H.; Nakai, Y.; Furuse, K.; Ohta, M.; Yamaguchi, Y.; Fujii, M.; Asakawa, M.; Horie, T.; Fukuoka, M.; Yoshida, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

166 A phase II study of CI-980 in advanc

✍ Vokes, E.; Masters, G.; Mauer, A.; Klepsch, A.; Lad, T.; Ratain, M.; Sciortino, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Phase II study of gemcitabine in non sma

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Oral etoposide preceding cisplatin in ad

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB

Phase II trial of oral Idarubicin in adv

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Phase II trial of oral Idarubicin in adv

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Paclitaxel (T) and carboplatin (C): A ph

✍ Fírvida, J.L; Amenedo, M; Salgado, M; Gonzalez-Quintas, A; Garcia Mata, J; Losad 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB